Complete Remission of Acute Myeloid Leukemia following Cisplatin Based Concurrent Therapy with Radiation for Squamous Cell Laryngeal Cancer.

• Type of Material: Article
• Authors: Mayur D. Mody, Emory University; Harpaul S. Gill, Emory University; Kristin Higgins, Emory University; Nabil Saba, Emory University; Vamsi Kota, Emory University
• Language: English
• Date: 2016
• Publisher: Hindawi Publishing Corporation
• Publication Version: Final Published Version
• Copyright Statement: © 2016 Mayur D. Mody et al.
• License: Creative Commons Attribution 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1155/2016/8581421
• Title of Journal or Parent Work: Case Reports in Hematology
• ISSN: 2090-6560
• Volume: 2016
• Start Page: 8581421
• End Page: 8581421
• Keywords: Hematology
• Research Categories: Health Sciences, Oncology; Health Sciences, Pharmacology

Abstract

Acute myeloid leukemia (AML) is a myeloid disorder with several established treatment regimens depending on patient and leukemic factors. Cisplatin is known to have strong leukemogenic potential and is rarely used even as salvage therapy in relapsed or refractory AML. We present a patient simultaneously diagnosed with AML and squamous cell carcinoma of the larynx, who was found to be in complete remission from AML following treatment with cisplatin based chemoradiotherapy for his laryngeal cancer.